Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
07/2014
07/08/2014CA2494715C Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry
07/03/2014WO2014104270A1 ANTIBODY RECOGNIZING FOLATE RECEPTORS α AND β
07/03/2014US20140187784 Radioactive quinolinone derivative and pharmaceutical drug comprising the same
07/03/2014US20140186263 Maleimide-functionalized gold nanoparticles
07/03/2014US20140186262 Novel gall bladder imaging agent and its preparation method
07/03/2014US20140186261 Anti-tumor agent and anti-tumor kit
07/03/2014US20140186260 Radiopharmaceutical and pharmaceutical kit
07/02/2014EP2749295A1 Radiopharmaceutical and pharmaceutical kit
07/02/2014EP2749294A1 Anti-tumor agent and anti-tumor kit
07/02/2014EP2748158A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals
07/02/2014CN103906743A 与血小板特异性糖蛋白IIb/IIIa结合的化合物以及其血栓成像的用途 Compound with a platelet-specific glycoprotein IIb / IIIa binding as well as its use for imaging thrombus
07/02/2014CN103893786A 一种放射核素<sup>131</sup>I-单克隆抗体标记物的制备方法 A method of preparing radionuclide <sup> 131 </ sup> I- radiation of monoclonal antibody markers
07/02/2014CN103893785A 化学放射性粒子和植入设备 Chemistry of radioactive particles and implantable devices
07/02/2014CN103159841B 一种<sup>99m</sup>Tc标记Cys-Annexin V的方法及其应用 One kind of <sup> 99m </ sup> Tc labeled Cys-Annexin V method and its application
07/02/2014CN102448933B 作为pbr配体的吲哚衍生物 As the indole derivative of the ligand pbr
07/02/2014CN102105174B 对金属蛋白酶选择性的诊断剂 Selectivity of metalloproteinases diagnostic agent
07/01/2014US8765818 Tannin formulation for treating GI spasms in a subject having Crohn's disease or ulcerative colitis
07/01/2014US8765097 Ligands to radiation-induced molecules
07/01/2014US8765096 Methods and compositions for treating and diagnosing kidney disease
06/2014
06/27/2014CA2836400A1 Radioactive quinolinone derivative and pharmaceutical drug comprising the same
06/26/2014WO2014100380A2 Multimodal particles, methods and uses thereof
06/26/2014WO2014100095A1 Methods and compositions for radiohalogen protein labeling
06/26/2014WO2014098593A1 Verapamil like compounds
06/26/2014WO2014097474A1 Novel compound for imaging tau protein accumulated in the brain
06/26/2014WO2014095833A1 Combination comprising radium-223 for the treatment of cancer
06/26/2014US20140179598 Somatostatin analogs with inhibitory activity to growth hormone release
06/26/2014US20140178304 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals
06/26/2014US20140178301 Polypeptides
06/26/2014US20140178300 Theranostic imaging agents and methods of use
06/26/2014US20140178298 Methods for tumor diagnosis and therapy
06/26/2014US20140178297 Seeds and Markers for Use in Imaging
06/26/2014US20140178296 Tumor-targeted nanodelivery systems to improve early mri detection of cancer
06/25/2014EP2745850A1 Nano-particles for internal radiation therapy of involved area, and therapy system
06/25/2014EP2744802A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
06/25/2014CN103889974A 放射性标记的化合物和它们在哺乳动物中作为磷酸二酯酶(pde10a)的定量成像的放射示踪剂的用途 Radiolabeled compounds and their use as phosphodiesterase (pde10a) quantitative imaging radiotracer in a mammal The use
06/25/2014CN103880887A 一种<sup>99m</sup>TcO-TYRDTC配合物及其制备方法和应用 One kind of <sup> 99m </ sup> TcO-TYRDTC complex and its preparation method and application
06/25/2014CN102311459B 新型锝-99m标记的高级脂肪酸衍生物 Higher fatty acid derivative labeled novel technetium -99m
06/25/2014CN101528115B 用于疼痛成像治疗的系统和方法 An imaging system and method for the treatment of pain
06/24/2014US8759499 Lipids for transfection of Eukaryotic cells
06/24/2014US8759490 Antibodies that bind OV064 and methods of use therefor
06/24/2014US8758811 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery
06/24/2014US8758752 RS7 antibodies
06/24/2014US8758726 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
06/24/2014US8758724 Unnatural amino acid radiolabeling precursor
06/24/2014US8758723 Compositions and methods for cellular imaging and therapy
06/24/2014US8758428 Coated implantable medical device
06/19/2014WO2014092958A1 Compositions and methods of diagnosing ocular diseases
06/19/2014WO2014092804A1 Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
06/19/2014WO2014039526A3 Carbamate compounds and methods of use in diseases of the nervous system
06/19/2014US20140171637 Process for the preparation of complexes of 68ga
06/19/2014US20140170148 Bispecific antibodies against her2
06/19/2014US20140170075 Non-invasive imaging methods for patient selection for treatment with nanoparticulate therapeutic agents
06/19/2014US20140170067 New ligands for targeting of s1p receptors for in vivo imaging and treatment of diseases
06/19/2014US20140170063 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
06/18/2014CN103861129A Recombinant human endostatin developer and its preparation method
06/18/2014CN103861128A Automatic preparation and quality control methods of positron and molecular imaging marking drugs
06/18/2014CN102452873B Compound containing carbon or oxygen isotope and preparation method thereof and application thereof and composition thereof
06/17/2014US8753666 Punctal plugs and methods of delivering therapeutic agents
06/17/2014US8753641 Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
06/17/2014US8753609 Fluid bed meal containing a marker and methods of making
06/17/2014US8753605 Imaging probes, methods of making imaging probes, and methods of imaging
06/12/2014WO2014086499A1 Neurotensin receptor ligands
06/12/2014WO2014086364A1 Positron emitting radionuclide labeled peptides for human upar pet imaging
06/12/2014WO2013186690A3 Radiolabeled analog(s) of compound 0118 and use thereof in connection with pet and/or spect imaging to determine whether a pharmaceutical containing compound 0118 is a candidate cancer treatment for a patient
06/12/2014US20140161724 Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
06/12/2014US20140161723 In vivo methods of monitoring biodistribution
06/11/2014EP2740726A1 Neurotensin receptor ligands
06/11/2014EP2739316A1 Radiolabeled prostate specific membrane antigen inhibitors
06/11/2014CN103857384A Method for the synthesis of porphyrin-phospholipid conjugates
06/10/2014US8748826 Radioimaging methods using teboroxime and thallium
06/10/2014US8748393 Inhibitors of mitochondrial fission and methods of use thereof
06/10/2014US8747839 Tracking of bone marrow cells for metastasis screening
06/10/2014US8747810 Compositions and methods for imaging tissues, organs and tumors
06/10/2014US8747809 Single diastereomers of 4-fluoroglutamine and methods of their preparation and use
06/10/2014US8747808 Radiolabeled annexins
06/05/2014WO2014085530A1 Methods of identifying surrogate imaging agents for alpha emitter radiopharmaceuticals and their use in treatment of disease
06/05/2014WO2014084372A1 Polypeptide and imaging method
06/05/2014WO2014083113A1 Crystallization process of tricyclic indole derivatives
06/05/2014WO2014082958A1 18f-labelled aldehyde compositions for radiofluorination
06/05/2014US20140154182 N,n-substituted guanidine compound
06/05/2014US20140154181 Rgd-containing peptidomimetics and uses thereof
06/05/2014US20140154179 Cxcr7 antagonists
06/04/2014CN103841994A Formulations of fluorinated stilbene suitable for pet imaging
06/04/2014CN103833829A Radioactive <18>F-labeled imaging drug <18>F-AL-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof
06/04/2014CN103830753A Imaging drug <68>Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof
06/04/2014CN101954097B Novel 18F labeled substituted benzimidazole compounds, preparation method thereof and PET tumor imaging application
06/03/2014US8741262 Targeted radiotherapy
06/03/2014US8741261 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
06/03/2014US8741259 Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
06/03/2014CA2443995C Endothelial cell expression patterns
05/2014
05/30/2014WO2014081655A1 Tin-1 17m comprising somatostatin receptor binding compounds
05/30/2014WO2014079977A1 Pharmaceutical formulations
05/30/2014WO2014079953A1 SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF
05/29/2014US20140147386 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
05/29/2014US20140147385 Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
05/29/2014US20140147384 Radioimmunoconjugates and uses thereof
05/29/2014US20140147383 Diagnosis and treatment of cancer using anti-gpr49 antibody
05/29/2014US20140147382 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
05/29/2014US20140147381 89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
05/29/2014US20140147380 Guanylylcyclase c ligands
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 243